Colorectal and Interval Cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2017 May 11

PMID 28487610

Citations 18

Authors

Isabel Portillo

Eunate Arana-Arri

Isabel Idigoras

Isabel Bilbao

Lorea Martinez-Indart

Luis Bujanda

Inaki Gutierrez-Ibarluzea

Affiliations

Soon will be listed here.

Abstract

Aim: To assess proportions, related conditions and survival of interval cancer (IC).

Methods: The programme has a linkage with different clinical databases and cancer registers to allow suitable evaluation. This evaluation involves the detection of ICs after a negative faecal inmunochemical test (FIT), interval cancer FIT (IC-FIT) prior to a subsequent invitation, and the detection of ICs after a positive FIT and confirmatory diagnosis without colorectal cancer (CRC) detected and before the following recommended colonoscopy, IC-colonoscopy. We conducted a retrospective observational study analyzing from January 2009 to December 2015 1193602 invited people onto the Programme (participation rate of 68.6%).

Results: Two thousand five hundred and eighteen cancers were diagnosed through the programme, 18 cases of IC-colonoscopy were found before the recommended follow-up (43542 colonoscopies performed) and 186 IC-FIT were identified before the following invitation of the 769200 negative FITs. There was no statistically significant relation between the predictor variables of ICs with sex, age and deprivation index, but there was relation between location and stage. Additionally, it was observed that there was less risk when the location was distal rather than proximal (OR = 0.28, 95%CI: 0.20-0.40, < 0.0001), with no statistical significance when the location was in the rectum as opposed to proximal. When comparing the screen-detected cancers (SCs) with ICs, significant differences in survival were found ( < 0.001); being the 5-years survival for SCs 91.6% and IC-FIT 77.8%.

Conclusion: These findings in a Population Based CRC Screening Programme indicate the need of population-based studies that continue analyzing related factors to improve their detection and reducing harm.

Citing Articles

Colorectal cancer screening: A review of current knowledge and progress in research.

Lopes S, Martins C, Santos I, Teixeira M, Gamito E, Alves A World J Gastrointest Oncol. 2024; 16(4):1119-1133.

PMID: 38660635 PMC: 11037045. DOI: 10.4251/wjgo.v16.i4.1119.

Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours.

Vanaclocha-Espi M, Pinto-Carbo M, Ibanez J, Valverde-Roig M, Portillo I, Perez-Riquelme F Cancers (Basel). 2024; 16(4).

PMID: 38398160 PMC: 10887036. DOI: 10.3390/cancers16040769.

Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot.

Saw K, Sexton K, Frankish P, Hulme-Moir M, Bissett I, Parry S BMJ Open Gastroenterol. 2023; 10(1).

PMID: 38007223 PMC: 10679982. DOI: 10.1136/bmjgast-2023-001233.

Histone crotonylation of peripheral blood mononuclear cells is a potential biomarker for diagnosis of colorectal cancer.

Hou J, Li N, Wang J, Gao L, Chang J, Cao J Epigenetics Chromatin. 2023; 16(1):35.

PMID: 37749610 PMC: 10521402. DOI: 10.1186/s13072-023-00509-3.

Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer-An Umbrella Review.

Switalski J, Tatara T, Wnuk K, Miazga W, Karauda D, Matera A Cancers (Basel). 2022; 14(18).

PMID: 36139551 PMC: 9496929. DOI: 10.3390/cancers14184391.

References

Dominguez-Berjon M, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarin M . [Constructing a deprivation index based on census data in large Spanish cities(the MEDEA project)]. Gac Sanit. 2008; 22(3):179-87. DOI: 10.1157/13123961. View

Robertson D, Lieberman D, Winawer S, Ahnen D, Baron J, Schatzkin A . Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2013; 63(6):949-56. PMC: 4383397. DOI: 10.1136/gutjnl-2012-303796. View

Digby J, Fraser C, Carey F, Lang J, Stanners G, Steele R . Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited. J Med Screen. 2015; 23(3):130-4. DOI: 10.1177/0969141315609634. View

Morris E, Whitehouse L, Farrell T, Nickerson C, Thomas J, Quirke P . A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer. 2012; 107(5):757-64. PMC: 3425974. DOI: 10.1038/bjc.2012.331. View

Hurtado J, Bacigalupe A, Calvo M, Esnaola S, Mendizabal N, Portillo I . Social inequalities in a population based colorectal cancer screening programme in the Basque Country. BMC Public Health. 2015; 15:1021. PMC: 4594998. DOI: 10.1186/s12889-015-2370-5. View

Moss S, Campbell C, Melia J, Coleman D, Smith S, Parker R . Performance measures in three rounds of the English bowel cancer screening pilot. Gut. 2011; 61(1):101-7. PMC: 3230830. DOI: 10.1136/gut.2010.236430. View

Zorzi M, Fedato C, Grazzini G, Stocco F, Banovich F, Bortoli A . High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut. 2011; 60(7):944-9. DOI: 10.1136/gut.2010.223982. View

Brenner H, Chang-Claude J, Seiler C, Hoffmeister M . Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2011; 61(11):1576-82. DOI: 10.1136/gutjnl-2011-301531. View

Sanduleanu S, le Clercq C, Dekker E, Meijer G, Rabeneck L, Rutter M . Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut. 2014; 64(8):1257-67. DOI: 10.1136/gutjnl-2014-307992. View

10.

le Clercq C, Bouwens M, Rondagh E, Bakker C, Keulen E, de Ridder R . Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 2013; 63(6):957-63. DOI: 10.1136/gutjnl-2013-304880. View

11.

Richter J, Campbell E, Chung D . Interval colorectal cancer after colonoscopy. Clin Colorectal Cancer. 2014; 14(1):46-51. DOI: 10.1016/j.clcc.2014.11.001. View

12.

Zubero M, Arana-Arri E, Pijoan J, Portillo I, Idigoras I, Lopez-Urrutia A . Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol. 2014; 4:175. PMC: 3887272. DOI: 10.3389/fphar.2013.00175. View

13.

Gill M, Bramble M, Hull M, Mills S, Morris E, Bradburn D . Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers. Br J Cancer. 2014; 111(11):2076-81. PMC: 4260027. DOI: 10.1038/bjc.2014.498. View

14.

Steele R, McClements P, Libby G, Carey F, Fraser C . Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis. 2013; 16(1):28-32. DOI: 10.1111/codi.12393. View

15.

Portillo I, Idigoras I, Ojembarrena E, Arana-Arri E, Zubero M, Pijoan J . [Main results of the colorectal cancer screening program in the Basque Country (Spain)]. Gac Sanit. 2013; 27(4):358-61. DOI: 10.1016/j.gaceta.2012.12.013. View

16.

Stegeman I, de Wijkerslooth T, Stoop E, van Leerdam M, van Ballegooijen M, Kraaijenhagen R . Risk factors for false positive and for false negative test results in screening with fecal occult blood testing. Int J Cancer. 2013; 133(10):2408-14. DOI: 10.1002/ijc.28242. View

17.

Samadder N, Curtin K, Tuohy T, Pappas L, Boucher K, Provenzale D . Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology. 2014; 146(4):950-60. DOI: 10.1053/j.gastro.2014.01.013. View

18.

Garcia M, Domenech X, Vidal C, Torne E, Mila N, Binefa G . Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain. Gastroenterol Res Pract. 2015; 2015:672410. PMC: 4354714. DOI: 10.1155/2015/672410. View

19.

Bujanda L, Sarasqueta C, Castells A, Pellise M, Cubiella J, Gil I . Colorectal cancer in a second round after a negative faecal immunochemical test. Eur J Gastroenterol Hepatol. 2015; 27(7):813-8. DOI: 10.1097/MEG.0000000000000366. View

20.

Steele R, Stanners G, Lang J, Brewster D, Carey F, Fraser C . Interval cancers in a national colorectal cancer screening programme. United European Gastroenterol J. 2016; 4(4):587-94. PMC: 4971793. DOI: 10.1177/2050640615624294. View